Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway
Cell Biology and Toxicology · 26.11.2024 · 40 (1)
DOI: 10.1007/s10565-024-09953-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, online erschienen am 26.11.2024. Verfasst von Yetong Feng und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of X…. Hauptthemen laut MEDLINE: Hydroxybenzoates, NF-E2-Related Factor 2, Ferroptosis, Signal Transduction. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Basic Research Program of Shaanxi Province, Research Foundation of the Second Affiliated Hospital of Xi'an Jiaotong University, Natural Science Foundation of Shaanxi Province.
Abstract (Originalsprache)
Ferroptosis represents a newly programmed cell death, and the process is usually accompanied with iron-dependent lipid peroxidation. Importantly, ferroptosis is implicated in a myriad of diseases. Recent literature suggests a potential position of ferroptosis in the pathogenesis of metabolic dysfunction-associated fatty liver disease (MAFLD), the most widespread liver ailment worldwide. Intriguingly, several functional genes and metabolic pathways central to ferroptosis are regulated by nuclear factor erythroid-derived 2-like 2 (NRF2). In current work, we aim to identify protocatechuic acid (PCA), a primary metabolite of antioxidant polyphenols, as a potent NRF2 activator and ferroptosis inhibitor in the hepatic lipotoxicity and steatosis models. Herein, both NRF2+/+ and NRF2-/- cell lines and mice were used to analyze the importance of NRF2 in PCA function, and hepatic lipotoxicity and steatosis models were induced by palmitic acid and high-fat diet respectively. Our results indicated that ferroptosis was mitigated by PCA intervention in hepatic cells. Furthermore, PCA exhibited therapeutic efficacy against ferroptosis, as well as hepatic lipotoxicity and steatosis. The protective role of PCA was predominantly mediated through NRF2 activation, potentially elucidating a pivotal mechanism underlying PCA's therapeutic impact on MAFLD. Additionally, the augmented mitochondrial TCA cycle activity observed in hepatic lipotoxicity and steatosis models was ameliorated by PCA, in part via NRF2-dependent pathways, further bolstering PCA's anti-ferroptosis properties. Collectively, our findings underscore PCA's potential in alleviating hepatic ferroptosis, lipotoxicity and steatosis via inducing activation of NRF2 signaling pathway, offering a promising strategy for the therapy of MAFLD as well as related lipid metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- International Joint Research Center On Cell Stress and Disease Diagnosis and Therapy, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong U…
- Core Research Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Shaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second, Xi'an, China.
- Department of Medical Image, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Regenerative Medicine, School of Pharmaceutical Science, Jilin University, Changchun, China.
Förderung
- Natural Science Basic Research Program of Shaanxi Province
- Research Foundation of the Second Affiliated Hospital of Xi'an Jiaotong University
- Natural Science Foundation of Shaanxi Province
- the Fundamental Research Funds for the Central Universities
- Medical "Base-Clinic" Integrated Innovation Project of Xi'an Jiaotong University
- Key Research and Development Program of Shaanxi Province
- National Natural Science Foundation of China
- Innovation Capability Support Program of Shaanxi Province
Zitieren
APA
Feng, Y., Shi, M., Zhang, Y., Li, X., Yan, L., Xu, J., Liu, C., Li, M., Bai, F., Yuan, F., Sun, Y., Liu, R., Zhao, Y., Yang, L., Zhang, Y., Guo, Y., Zhang, J., Zhou, R., & Liu, P. (2024). Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway. Cell Biology and Toxicology, 40(1). https://doi.org/10.1007/s10565-024-09953-7
Vancouver
Feng Y, Shi M, Zhang Y, Li X, Yan L, Xu J, et al. Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway. Cell Biology and Toxicology. 2024;40(1). doi:10.1007/s10565-024-09953-7
BibTeX
@article{Feng2024,
author = {Feng, Yetong and Shi, Mengjiao and Zhang, Yi and Li, Xinyan and Yan, Liangwen and Xu, Jiayi and Liu, Chenyue and Li, Miaomiao and Bai, Fengyun and Yuan, Fenyue and Sun, Ying and Liu, Rongrong and Zhao, Yaping and Yang, Lan and Zhang, Yinggang and Guo, Ying and Zhang, Jian and Zhou, Rui and Liu, Pengfei},
title = {Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway},
journal = {Cell Biology and Toxicology},
year = {2024},
volume = {40},
number = {1},
doi = {10.1007/s10565-024-09953-7}
}
EUVIMED